Utilization of Rad51C promoter for transcriptional targeting of cancer cells. - Wikidata - wikimedia - TriplyDB

Utilization of Rad51C promoter for transcriptional targeting of cancer cells.

Utilization of Rad51C promoter for transcriptional targeting of cancer cells.

http://www.wikidata.org/entity/Q33688410

about

Frizzled-7 promoter is highly active in tumors and promoter-driven Shiga-like toxin I inhibits hepatocellular carcinoma growth.Use of the XRCC2 promoter for in vivo cancer diagnosis and therapy.

P2860

Q36545508-36AB862B-6A61-418A-908B-C91EDD7F7F7E Q52651261-0F43E53D-AAD4-4F2C-B333-39CCD194B8A0

P2860

Utilization of Rad51C promoter for transcriptional targeting of cancer cells.

http://www.wikidata.org/entity/Q33688410

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Utilization of Rad51C promoter for transcriptional targeting of cancer cells.

@ast

Utilization of Rad51C promoter for transcriptional targeting of cancer cells.

@en

type

label

Utilization of Rad51C promoter for transcriptional targeting of cancer cells.

@ast

Utilization of Rad51C promoter for transcriptional targeting of cancer cells.

@en

prefLabel

Utilization of Rad51C promoter for transcriptional targeting of cancer cells.

@ast

Utilization of Rad51C promoter for transcriptional targeting of cancer cells.

@en

P1433

Q33688410-C0A5E16A-8997-4D18-8029-23764371B6F9

P1476

Q33688410-EDC8B4B1-3B76-42D4-B6D9-3B0A535CF78A

P2093

Q33688410-246E714D-90A4-478E-B06C-AC1877C3F188

Q33688410-3271B3A1-2589-4063-A26A-9591256E65A8

Q33688410-5AC16BB4-9677-4B67-9A58-EB79A344725D

Q33688410-927DCFB7-4210-468F-8237-78CC3CC0BD41

Q33688410-A4F03D58-09C8-414C-9ED9-E8F3271623D9

Q33688410-A6A0613C-05B5-40C6-A80B-57825BEA15B5

Q33688410-EB61E668-6504-4B2B-B4CB-F0183442EE3A

Q33688410-FE45ED89-8F59-495B-849B-5CC27A3FC925

P2860

Q33688410-004CE1A5-84C2-4B03-819A-BB8EA255AA8C

Q33688410-00AA2B6D-1501-4AE5-A4F0-311FD6439C69

Q33688410-01106F2E-6CDA-4EC6-B19B-8D48FDF1A885

Q33688410-0FEFEE5D-BF40-4B5D-BD99-1AC5DA392BC8

Q33688410-1BEC66AD-4CAF-4288-869D-E171C00CB9B1

Q33688410-33F0C7FD-9535-4F61-814E-E434F5B1074C

Q33688410-35071D33-4144-491B-9392-137228CAC7D3

Q33688410-431DDEF2-E162-444F-97B0-33613CCD3577

Q33688410-48C1DDEE-26D2-47E1-8BD4-C158FBA58AA3

Q33688410-510A48E0-A594-494A-B57F-4596882EF402

P304

Q33688410-6FE909D1-8C12-40E0-A770-CB862F2AE6A7

P31

Q33688410-512DDC15-9214-4BEF-A055-89180830B3EE

P356

Q33688410-1EE50627-4035-4A97-9D9B-B3BC33868E61

P407

Q33688410-F5B4879E-4B2D-4D6C-B464-4D0BA5C5A900

P433

Q33688410-0A479902-28DC-4653-9573-5912E96C2F5A

P478

Q33688410-415050D8-CDAA-4D42-9753-59D05674D144

P50

Q33688410-79EC1B09-684C-4309-BB59-9C3AE6B8B208

P577

Q33688410-904E8B64-6365-41CD-93BE-2446BD99EE48

P5875

Q33688410-1634FE37-F39E-4B31-B678-4ED804D37089

P698

Q33688410-D1A1F0C3-9757-490A-AFF0-A96DEEACB8C1

P932

Q33688410-6E12A96D-052C-4833-8D25-2EC478E9F3C1

P356

ONCOTARGET.1792

P1433

P1476

Utilization of Rad51C promoter for transcriptional targeting of cancer cells

@en

P2093

Andrei Seluanov

http://www.w3.org/2001/XMLSchema#string

Lei Zhang

http://www.w3.org/2001/XMLSchema#string

Xiao Tian

http://www.w3.org/2001/XMLSchema#string

Yan Cao

http://www.w3.org/2001/XMLSchema#string

Yan Xu

http://www.w3.org/2001/XMLSchema#string

Ying Jiang

http://www.w3.org/2001/XMLSchema#string

Zhen Li

http://www.w3.org/2001/XMLSchema#string

Zhiyong Mao

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and purification of two distinct complexes containing the five RAD51 paralogs

RAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylation

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma

Use of transcriptional regulatory sequences of telomerase (hTER and hTERT) for selective killing of cancer cells

Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

Stimulation by Rad52 of yeast Rad51-mediated recombination

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

Disruption of muREC2/RAD51L1 in mice results in early embryonic lethality which can Be partially rescued in a p53(-/-) background

RAD51C deficiency in mice results in early prophase I arrest in males and sister chromatid separation at metaphase II in females

P304

1805-1811

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.1792

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261756358

http://www.w3.org/2001/XMLSchema#string

P698

24742710

http://www.w3.org/2001/XMLSchema#string

P932

4039114

http://www.w3.org/2001/XMLSchema#string